CMS Announces Two Quality and Safety Initiatives Related to Antipsychotic Medication

On Jan. 18, the Center for Medicare and Medicaid Services (CMS) announced two initiatives in quality and safety oversight memo 23-05-NH in response to the Biden-Harris administration effort to improve nursing home transparency, safety, and quality. CMS intends to conduct offsite nursing home audits to determine if the nursing home correctly coded diagnoses for residents using antipsychotic medication. CMS will change how citations under dispute are posted.